GQG Partners LLC Invests $1.63 Billion in Cigna Group $CI

GQG Partners LLC acquired a new stake in Cigna Group (NYSE:CI) during the second quarter, Holdings Channel reports. The institutional investor acquired 5,908,707 shares of the health services provider’s stock, valued at approximately $1,628,918,000. Cigna Group accounts for about 3.0% of GQG Partners LLC’s portfolio, making the stock its 7th biggest position.

Other institutional investors have also made changes to their positions in the company. Wilkerson Advisory Group LLC acquired a new position in shares of Cigna Group during the 4th quarter worth about $25,000. Cedar Mountain Advisors LLC boosted its stake in shares of Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after acquiring an additional 68 shares during the period. Johnson Financial Group Inc. bought a new position in Cigna Group during the second quarter worth $29,000. Kemnay Advisory Services Inc. bought a new stake in shares of Cigna Group during the 4th quarter worth about $29,000. Finally, Prosperity Bancshares Inc bought a new stake in shares of Cigna Group during the fourth quarter worth approximately $29,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 0.6%

Shares of CI stock opened at $276.19 on Friday. The stock has a market cap of $72.98 billion, a P/E ratio of 11.43, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a 50 day simple moving average of $284.20 and a 200 day simple moving average of $281.38.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company’s revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the company earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, research analysts predict that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Analysts Set New Price Targets

CI has been the subject of several recent research reports. Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price target for the company from $350.00 to $320.00 in a research note on Monday, August 3rd. Robert W. Baird set a $362.00 price objective on Cigna Group in a research report on Friday, July 31st. Wolfe Research reissued an “outperform” rating and set a $315.00 target price on shares of Cigna Group in a report on Tuesday, June 16th. Morgan Stanley boosted their target price on shares of Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research report on Wednesday, May 20th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Insiders Place Their Bets

In other Cigna Group news, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 23,012 shares of company stock worth $6,386,550 in the last 90 days. 0.60% of the stock is owned by company insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.